mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.013 |
0.9 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.0033 |
0.9 |